Promise and problems of Bcl-2 antisense therapy.

Journal of the National Cancer Institute

Volumn 89, Issue 14, 1997, Pages 988-990

  Reed, J C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; PROTEIN BCL 2;

APOPTOSIS; BIOSYNTHESIS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; HUMAN; MULTIDRUG RESISTANCE; NEOPLASM; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0031575073     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.14.988     Document Type: Note

References (36)